Annotated abstract

Weight loss drugs: Semaglutide boosts heart health regardless of how much weight patients lose, study suggests

bmj · 2025-10-23 · canonical JSON source

2 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person loses or their starting body weight, new analysis suggests.1